Comparison of inhaled corticosteroids (Q41718750)

8 October 2017

1 reference

title

Comparison of inhaled corticosteroids (English)

1 reference

8 October 2017

H W Kelly

1

1 reference

PubMed ID

9496409

8 October 2017

language of work or name

English

0 references

publication date

1 February 1998

1 reference

Annals of Pharmacotherapy

8 October 2017

1 reference

8 October 2017

32

1 reference

8 October 2017

2

1 reference

8 October 2017

220-232

1 reference

Efficacy and safety of inhaled corticosteroids in asthma. Report of a workshop held in Eze, France, October 1992.

8 October 2017

1 reference

Inhaled glucocorticoids for asthma

21 January 2018

1 reference

Issues in the use of inhaled glucocorticoids. The Asthma Clinical Research Network

21 January 2018

1 reference

Airway and systemic effects of inhaled corticosteroids in asthma: dose response relationship

21 January 2018

1 reference

Corticosteroid pharmacodynamics: models for a broad array of receptor-mediated pharmacologic effects

21 January 2018

1 reference

Glucocorticoid therapy for asthma: clinical pharmacology

21 January 2018

1 reference

The influence of orally deposited budesonide on the systemic availability of budesonide after inhalation from a Turbuhaler

21 January 2018

1 reference

Budesonide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in asthma and rhinitis

21 January 2018

1 reference

Absorption and metabolism of orally administered beclomethsone dipropionate.

21 January 2018

1 reference

Activation of beclomethasone dipropionate by hydrolysis to beclomethasone-17-monopropionate

21 January 2018

1 reference

New perspectives on inhaled drug delivery and systemic bioactivity

21 January 2018

1 reference

Inhalational drug delivery from seven different spacer devices

21 January 2018

1 reference

Differences in output from corticosteroid inhalers used with a volumatic spacer

21 January 2018

1 reference

Exhaled nitric oxide: a new lung function test

21 January 2018

1 reference

Long-, intermediate- and short-term growth studies in asthmatic children treated with inhaled glucocorticosteroids

21 January 2018

1 reference

Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma

21 January 2018

1 reference

Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics

21 January 2018

1 reference

Influence of treatment on peak expiratory flow and its relation to airway hyperresponsiveness and symptoms. The Dutch CNSLD Study Group

21 January 2018

1 reference

Importance of the inhalation device on the effect of budesonide

21 January 2018

1 reference

Use of inhaled corticosteroids in patients with mild asthma

21 January 2018

1 reference

Influence of dosing frequency and schedule on the response of chronic asthmatics to the aerosol steroid, budesonide

21 January 2018

1 reference

Four-times-a-day dosing frequency is better than a twice-a-day regimen in subjects requiring a high-dose inhaled steroid, budesonide, to control moderate to severe asthma

21 January 2018

1 reference

Asthma treatment with a new corticosteroid aerosol, budesonide, administered twice daily by spacer inhaler

21 January 2018

1 reference

Comparison of two high dose corticosteroid aerosol treatments, beclomethasone dipropionate (1500 micrograms/day) and budesonide (1600 micrograms/day), for chronic asthma

21 January 2018

1 reference

Comparison of budesonide and beclomethasone dipropionate for treatment of asthma

21 January 2018

1 reference

High-dose inhaled steroids in the management of asthma. A comparison of the effects of budesonide and beclomethasone dipropionate on pulmonary function, symptoms, bronchial responsiveness and the adrenal function

21 January 2018

1 reference

Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma

21 January 2018

1 reference

Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group

21 January 2018

1 reference

A dose-ranging study of fluticasone propionate in adult patients with moderate asthma. International Study Group

21 January 2018

1 reference

Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine

21 January 2018

1 reference

Do large volume spacer devices reduce the systemic effects of high dose inhaled corticosteroids?

21 January 2018

1 reference

Effect of a volumatic spacer and mouth rinsing on systemic absorption of inhaled corticosteroids from a metered dose inhaler and dry powder inhaler

21 January 2018

1 reference

Systemic effects of high dose inhaled steroids: comparison of beclomethasone dipropionate and budesonide in healthy subjects

21 January 2018

1 reference

An assessment of the systemic activity of single doses of inhaled fluticasone propionate in healthy volunteers

21 January 2018

1 reference

A comparison of the systemic bioactivity of inhaled budesonide and fluticasone propionate in normal subjects

21 January 2018

1 reference

Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients

21 January 2018

1 reference

Adrenal suppression with inhaled budesonide and fluticasone propionate given by large volume spacer to asthmatic children

21 January 2018

1 reference

Assessment of the relative systemic potency of inhaled fluticasone and budesonide.

21 January 2018

1 reference

Adrenal function in children with bronchial asthma treated with beclomethasone dipropionate or budesonide

21 January 2018

1 reference

Molecular actions of glucocorticoids: an introduction

21 January 2018

1 reference

Structure-activity relationships of topically active steroids: the selection of fluticasone propionate

21 January 2018

1 reference

Corticosteroid Action and Resistance in Asthma. Proceedings of a meeting. Buckinghamshire, United Kingdom, October 1995

21 January 2018

1 reference

Flunisolide metabolism and dynamics of a metabolite

21 January 2018

1 reference

Pharmacokinetics of triamcinolone acetonide and its phosphate ester

21 January 2018

1 reference

Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI

21 January 2018

1 reference

Correlation of flunisolide plasma levels to eosinopenic response in humans

21 January 2018

1 reference

Choosing the metered-dose inhaler spacer or holding chamber that matches the patient's need: evidence that the specific drug being delivered is an important consideration

21 January 2018

1 reference

Spontaneous and induced sputum to measure indices of airway inflammation in asthma

21 January 2018

1 reference

Effects of inhaled budesonide on allergen-induced airway responses and airway inflammation

21 January 2018

1 reference

Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients

21 January 2018

1 reference

Inhaled corticosteroids: benefits and risks

21 January 2018

1 reference

Effect of inhaled corticosteroids on bone

21 January 2018

1 reference

The long-term effects of nedocromil sodium and beclomethasone dipropionate on bronchial responsiveness to methacholine in nonatopic asthmatic subjects

21 January 2018

1 reference

Dosage and time effects of inhaled budesonide on bronchial hyperreactivity

21 January 2018

1 reference

A methodological assessment of diurnal variability of peak flow as a basis for comparing different inhaled steroid formulations

21 January 2018

1 reference

Budesonide treatment of moderate and severe asthma in children: a dose-response study

21 January 2018

1 reference

Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma

21 January 2018

1 reference

Cessation of long-term treatment with inhaled corticosteroid (budesonide) in children with asthma results in deterioration. The Dutch CNSLD Study Group

21 January 2018

1 reference

Six-month double-blind, controlled trial of high dose, concentrated beclomethasone dipropionate in the treatment of severe chronic asthma

21 January 2018

1 reference

Comparison of twice daily administration of a new corticosteroid budesonide with beclomethasone dipropionate four times daily in the treatment of chronic asthma

21 January 2018

1 reference

Comparison of budesonide and beclomethasone dipropionate in patients with severe chronic asthma: assessment of relative prednisolone-sparing effects

21 January 2018

1 reference

A comparison of inhaled budesonide and beclomethasone dipropionate in childhood asthma

21 January 2018

1 reference

Evaluation of fluticasone propionate (500 micrograms day-1) administered either as dry powder via a Diskhaler inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 micrograms day-1) administered by pressurized inhaler

21 January 2018

1 reference

A comparison of fluticasone propionate 200 micrograms/day with beclomethasone dipropionate 400 micrograms/day in adult asthma

21 January 2018

1 reference

High-dose inhaled steroids in asthmatics: moderate efficacy gain and suppression of the hypothalamic-pituitary-adrenal (HPA) axis. Research Council of the Norwegian Thoracic Society

21 January 2018

1 reference

Pulmonary and critical care procedures. Under the spotlight

21 January 2018

1 reference

A bioassay for topical and systemic effect of three inhaled corticosteroids

21 January 2018

1 reference

Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma

21 January 2018

1 reference

Adrenocortical suppression following treatment with beclomethasone and budesonide

21 January 2018

1 reference

Adrenocortical function in children on high-dose steroid aerosol therapy. Results of serum cortisol, ACTH stimulation test and 24 hour urinary free cortical excretion

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.17014

1 reference

8 October 2017

1 reference

PubMed ID

9496409